Harmful effects of transfusion of older stored red blood cells: Iron and inflammation

Transfusion

Volumn 51, Issue 4, 2011, Pages 881-885

  Hod, Eldad A ^a   Spitalnik, Steven L ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b Surgeons of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEMOGLOBIN; IRON;

ALLOGRAFT; BETA THALASSEMIA; CONFERENCE PAPER; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; FOOD AND DRUG ADMINISTRATION; HEMATOPOIETIC SYSTEM; HUMAN; INFLAMMATION; MONOCYTE MACROPHAGE SYSTEM; NONHUMAN; OUTCOME ASSESSMENT; SICKLE CELL ANEMIA;

BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; INFLAMMATION; IRON;

EID: 79954603823     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03096.x     Document Type: Conference Paper

References (25)

1. Tinmouth A, Fergusson D, Yee IC, Hebert PC,. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46: 2014-27. (Pubitemid 44631611)
2. Dumont LJ, AuBuchon JP,. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008; 48: 1053-60. (Pubitemid 351793478)
3. Luten M, Roerdinkholder-Stoelwinder B, Schaap NP, de Grip WJ, Bos HJ, Bosman GJ,. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion 2008; 48: 1478-85.
4. Zeiler T, Muller JT, Kretschmer V,. Flow-cytometric determination of survival time and 24-hour recovery of transfused red blood cells. Transfus Med Hemother 2003; 30: 14-9. (Pubitemid 37499839)
5. Gilson CR, Kraus T, Hod EA, Hendrickson J, Spitalnik SL, Hillyer CD, Shaz B, Zimring JC,. Mouse RBCs stored in CPDA-1 have similar characteristics to the established properties of stored human RBCs. Transfusion 2009; 49: 1546-53.
6. Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D, Francis KP, Della-Latta P, Whittier S, Sheth S, Hendrickson JE, Zimring JC, Brittenham GM, Spitalnik SL,. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010; 115: 4284-92.
7. Kaye D, Gill FA, Hook EW,. Factors influencing host resistance to Salmonella infections: the effects of hemolysis and erythrophagocytosis. Am J Med Sci 1967; 254: 205-15.
8. Kaye D, Hook EW,. The influence of hemolysis or blood loss on susceptibility to infection. J Immunol 1963; 91: 65-75.
9. Loegering DJ, Grover GJ, Schneidkraut MJ,. Effect of red blood cells and red blood cell ghosts on reticuloendothelial system function. Exp Mol Pathol 1984; 41: 67-73. (Pubitemid 14028934)
10. Loegering DJ, Commins LM, Minnear FL, Gary LA, Hill LA,. Effect of Kupffer cell phagocytosis of erythrocytes and erythrocyte ghosts on susceptibility to endotoxemia and bacteremia. Infect Immun 1987; 55: 2074-80. (Pubitemid 17139285)
11. Wood RJ,. The iron-heart disease connection: is it dead or just hiding? Ageing Res Rev 2004; 3: 355-67. (Pubitemid 38844700)
12. Koppenol WH,. The Haber-Weiss cyclea′70 years later. Redox Rep 2001; 6: 229-34.
13. Eisenstein RS,. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000; 20: 627-62.
14. Theil EC,. Ferritin: structure, function, and regulation. Adv Inorg Biochem 1983; 5: 1-38.
15. Gangaidzo IT, Moyo VM, Mvundura E, Aggrey G, Murphree NL, Khumalo H, Saungweme T, Kasvosve I, Gomo ZA, Rouault T, Boelaert JR, Gordeuk VR,. Association of pulmonary tuberculosis with increased dietary iron. J Infect Dis 2001; 184: 936-9. (Pubitemid 32881103)
16. Magnus SA, Hambleton IR, Moosdeen F, Serjeant GR,. Recurrent infections in homozygous sickle cell disease. Arch Dis Child 1999; 80: 537-41. (Pubitemid 29264367)
17. Wanachiwanawin W,. Infections in E-beta thalassemia. J Pediatr Hematol Oncol 2000; 22: 581-7.
18. Barry DM, Reeve AW,. Increased incidence of gram-negative neonatal sepsis with intramuscular iron administration. Pediatrics 1977; 60: 908-12. (Pubitemid 8249279)
19. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM,. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006; 367: 133-43. (Pubitemid 43077129)
20. WHO. Conclusions and recommendations of the WHO consultation on prevention and control of iron deficiency in infants and young children in malaria-endemic areas. Food Nutr Bull 2007; 28: S621-7.
21. Dresow B, Petersen D, Fischer R, Nielsen P,. Non-transferrin-bound iron in plasma following administration of oral iron drugs. Biometals 2008; 21: 273-6. (Pubitemid 351579742)
22. Hider RC,. Nature of nontransferrin-bound iron. Eur J Clin Invest 2002; 32 (Suppl 1): 50-4. (Pubitemid 41704988)
23. Hershko C,. Mechanism of iron toxicity. Food Nutr Bull 2007; 28: S500-9. (Pubitemid 351149500)
24. van Tits LJ, Jacobs EM, Swinkels DW, Lemmers HL, van der Vleuten GM, de Graaf J, Stalenhoef AF,. Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation. Atherosclerosis 2007; 194: 272-8. (Pubitemid 47464306)
25. Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM,. Iron depletion limits intracellular bacterial growth in macrophages. Blood 2008; 112: 866-74.